Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | OZA, A. M. | |
dc.contributor.author | SELLE, F. | |
dc.contributor.author | DAVIDENKO, I. | |
dc.contributor.author | KORACH, J. | |
dc.contributor.author | MENDIOLA, C. | |
dc.contributor.author | GOCZE, P. | |
dc.contributor.author | PAUTIER, P. | |
dc.contributor.author | CHMIELOWSKA, E. | |
dc.contributor.author | BAMIAS, A. | |
dc.contributor.author | DECENSI, A. | |
dc.contributor.author | ZVIRBULE, Z. | |
dc.contributor.author | GONZALEZ-MARTIN, A. | |
dc.contributor.author | HEGG, R. | |
dc.contributor.author | JOLY, F. | |
dc.contributor.author | ZAMAGNI, C. | |
dc.contributor.author | GADDUCCI, A. | |
dc.contributor.author | DEURLOO, R. | |
dc.contributor.author | REVIL, C. | |
dc.contributor.author | ROBB, S. | |
dc.contributor.author | COLOMBO, N. | |
dc.date.accessioned | 2016-03-24T15:00:28Z | |
dc.date.available | 2016-03-24T15:00:28Z | |
dc.date.issued | 2015 | |
dc.description.conferencedate | 2015 | |
dc.description.conferencelocal | Vienna, AUSTRIA | |
dc.description.conferencename | European Cancer Congress | |
dc.description.index | MEDLINE | |
dc.identifier.citation | EUROPEAN JOURNAL OF CANCER, v.51, suppl.3, p.S532-S532, 2015 | |
dc.identifier.eissn | 1879-0852 | |
dc.identifier.issn | 0959-8049 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/13752 | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER SCI LTD | |
dc.relation.ispartof | European Journal of Cancer | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright ELSEVIER SCI LTD | |
dc.subject.wos | Oncology | |
dc.title | Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC) | |
dc.type | conferenceObject | |
dc.type.category | meeting abstract | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Rússia | |
hcfmusp.affiliation.country | Suíça | |
hcfmusp.affiliation.country | Letônia | |
hcfmusp.affiliation.country | Itália | |
hcfmusp.affiliation.country | Grécia | |
hcfmusp.affiliation.country | Polônia | |
hcfmusp.affiliation.country | Hungria | |
hcfmusp.affiliation.country | Espanha | |
hcfmusp.affiliation.country | Israel | |
hcfmusp.affiliation.country | França | |
hcfmusp.affiliation.country | Canadá | |
hcfmusp.affiliation.countryiso | it | |
hcfmusp.affiliation.countryiso | ca | |
hcfmusp.affiliation.countryiso | fr | |
hcfmusp.affiliation.countryiso | ru | |
hcfmusp.affiliation.countryiso | il | |
hcfmusp.affiliation.countryiso | es | |
hcfmusp.affiliation.countryiso | hu | |
hcfmusp.affiliation.countryiso | pl | |
hcfmusp.affiliation.countryiso | gr | |
hcfmusp.affiliation.countryiso | lv | |
hcfmusp.affiliation.countryiso | ch | |
hcfmusp.author.external | OZA, A. M.:Univ Toronto, Princess Margaret Hosp, Med Oncol & Hematol, Toronto, ON, Canada | |
hcfmusp.author.external | SELLE, F.:Tenon Hosp, AP HP, Paris, France; Alliance Rech Cancerol, Med Oncol, Paris, France | |
hcfmusp.author.external | DAVIDENKO, I.:Krasnodar Region Minist Healthcare, Dept Chemotherapy, State Budgetary Healthcare Inst, Clin Oncol Dispensary 1, Krasnodar, Russia | |
hcfmusp.author.external | KORACH, J.:Chaim Sheba Med Ctr, Dept Gynecol Oncol, IL-52621 Tel Hashomer, Israel | |
hcfmusp.author.external | MENDIOLA, C.:Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain | |
hcfmusp.author.external | GOCZE, P.:Univ Pecs, Dept Obstet & Gynecol, Fac Med, Pecs, Hungary | |
hcfmusp.author.external | PAUTIER, P.:Inst Gustave Roussy, Dept Med, Villejuif, France | |
hcfmusp.author.external | CHMIELOWSKA, E.:Oncol Ctr Prof F Lukaszczyka, Dept Clin Oncol, Bydgoszcz, Poland | |
hcfmusp.author.external | BAMIAS, A.:Alexandra Peripheral Gen Hosp, Dept Clin Therapeut, Athens, Greece | |
hcfmusp.author.external | DECENSI, A.:EO Osped Galliera, Med Oncol, Genoa, Italy | |
hcfmusp.author.external | ZVIRBULE, Z.:Riga East Univ Hosp, Latvian Oncol Ctr, Med Oncol, Riga, Latvia | |
hcfmusp.author.external | GONZALEZ-MARTIN, A.:MD Anderson Canc Ctr Spain, Dept Med Oncol, Madrid, Spain | |
hcfmusp.author.external | JOLY, F.:Ctr Francois Baclesse, Dept Med Oncol, F-14021 Caen, France | |
hcfmusp.author.external | ZAMAGNI, C.:St Orsola Marcello Malpighi Hosp, Med Oncol, Bologna, Italy | |
hcfmusp.author.external | GADDUCCI, A.:Univ Pisa, Div Obstet & Gynecol, Dept Expt & Clin Med, Pisa, Italy | |
hcfmusp.author.external | DEURLOO, R.:F Hoffmann La Roche Ltd, Oncol Biomarker Dev, Basel, Switzerland | |
hcfmusp.author.external | REVIL, C.:F Hoffmann La Roche Ltd, Stamford Consultants AG, Global Med Affairs Biometr, Basel, Switzerland | |
hcfmusp.author.external | ROBB, S.:F Hoffmann La Roche & Co Ltd, Global Med Affairs, CH-4002 Basel, Switzerland | |
hcfmusp.author.external | COLOMBO, N.:European Inst Oncol, Milan, Italy; Univ Milano Bicocca, Div Med Gynecol Oncol, Milan, Italy | |
hcfmusp.contributor.author-fmusphc | ROBERTO HEGG | |
hcfmusp.description.beginpage | S532 | |
hcfmusp.description.endpage | S532 | |
hcfmusp.description.issue | suppl 3 | |
hcfmusp.description.volume | 51 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000361887402356 | |
hcfmusp.publisher.city | OXFORD | |
hcfmusp.publisher.country | ENGLAND | |
relation.isAuthorOfPublication | 137bc9f4-67c1-49b4-b313-66cbbeae2781 | |
relation.isAuthorOfPublication.latestForDiscovery | 137bc9f4-67c1-49b4-b313-66cbbeae2781 |